A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Kyowa Hakko

Company-logo  COMPANY DETAILS
Kyowa Hakko
Am Wehrhahn 50
40211 Düsseldorf
Germany
Website
Mail
Call

+49 211 175 450




HEALTH CATEGORIES

aging; brain/mood health; energy and alertness; eye health; immune health; medical nutrition; nutraceuticals; plant-based; sports nutrition; supplements; vegan


Linkedin   
Twitter   

Kyowa Hakko offers a line of well-researched, branded ingredients and an extensive portfolio of quality-assured, ultra-pure amino acids, paraprobiotics, vitamins, nucleic acids and related compounds for use in pharmaceutical and nutritional applications.

Manufactured exclusively by KYOWA HAKKO BIO CO., LTD., a global specialty fermentation company, Kyowa’s branded ingredients are backed by 60 years of research and innovation to deliver targeted, condition-specific consumer health benefits.

Our core business areas:

  • Pharmaceuticals
  • Supplements & Nutrition



Pharmaceuticals
Pharmaceutical companies around the world purchase our high-quality Active Pharmaceutical Ingredients and excipients that can be used in a wide variety of pharmaceutical applications.

Supplement & Nutrition
Kyowa is committed to ongoing scientific research, quality management and consumer education for its products. Kyowa’s branded ingredients have been designed to deliver targeted, condition-specific consumer health benefits and are backed by science.

Products / Markets

 Click to Enlarge








Our ingredients bear the Kyowa Quality mark, which means that all products are manufactured to meet highest quality assurance standards, supplying quality and trusted materials for various industries such as pharmaceuticals, foods, and cosmetics.


Key branded ingredients include:

IMMUSE®, Lactococcus lactis strain Plasma

IMMUSE®, is the ?rst paraprobiotic ingredient clinically researched to directly activate pDC (plasmacytoid dendritic cells), a rare subset of immune cells, providing comprehensive innate and adaptive immune support.  Backed by 26 studies, including 11 human trials, add IMMUSE®, to your next product.


Setria® Glutathione

Known as ‘The Master Antioxidant’, Setria® Glutathione is a tripeptide composed of L-Glutamic acid, L-Cysteine and Glycine.  Setria® helps protect cells from the damaging effects of toxins and oxidative stress and plays a key role in supporting immune function. 


Setria® Performance Blend

Setria® Performance Blend is a clinically researched blend of glutathione and made in the USA L-Citrulline that may support nitric oxide production. New research in resistance-trained males suggests that  Setria® Performance Blend may help sustain NO levels which could lead to reduced fatigue and speed post-workout recovery. 

Cognizin® Citicoline

Cognizin® Citicoline is a proprietary brain-health nutrient that has been clinically shown to support mental energy, focus, attention and recall. Cognizin® is approved as Novel Food Ingredient in the European Union and can be added to food supplements and food for special medical purposes.


VELOX Patented Performance Blend

VELOX Blend is a clinically studied blend of two made in the USA amino acids—L-Citrulline and L-Arginine— that has been shown to boost Nitric Oxide levels more rapidly than L-Arginine alone. Help your customers achieve their personal best with VELOX Patented Performance Blend .




Articles On Nutrition Insight

NUTRITION & HEALTH NEWS

Beyond the Headlines: FrieslandCampina Ingredients supplies prebiotics to Australia, TopGum debuts cappuccino gummies

05 May 2023 --- This week in nutrition news, FrieslandCampina Ingredients has secured approval for its Biotis galacto-oligosaccharides (GOS) to be used in gut health supplements in Australia.... Read More

BUSINESS NEWS

Beyond The Headlines: DSM expands reach of HMOs, Kyowa Hakko beverage targets brain health

10 Feb 2023 --- This week in nutrition news, Royal DSM received regulatory approval for its human milk oligosaccharide (HMO) 3-fucosyllactose (3-FL) ingredient in the US and Australia. Kyowa Hakko... Read More

NUTRITION & HEALTH NEWS

Vitafoods Asia 2022: Supplement opportunities from “womb to adulthood” across APAC market

19 Sep 2022 --- As industry adjusts to a myriad of developments ranging from consumer demands to a vastly changing regulatory landscape, companies are eyeing opportunities across the APAC region.... Read More

NUTRITION & HEALTH NEWS

E-gaming potential at the fingertips? Kyowa Hakko unveils supplement impact on tapping speed

12 Aug 2022 --- Kyowa Hakko USA is launching the “Tap Challenge Game” app, enabling e-gamers to see the effects of the company’s citicoline supplement, Cognizin, on their finger... Read More

NUTRITION & HEALTH NEWS

Stratum Nutrition pegs postbiotics as “viable alternative” for infant microbiome support

27 Jul 2022 --- Postbiotics are seeing increasing interest in targeting a healthy gut microbiome for infants, according to Stratum Nutrition. Though prebiotics and probiotics are proliferating the... Read More




Videos
FormattedPicture

Kyowa Hakko Bio spotlights HMOs’ potential in Chinese and Thai markets

26 Jan 2021 --- In light of the increasing global demand for HMOs, Kyowa Hakko Bio is eyeing opportunities within the Chinese and Thai markets, despite a hazy regulatory environment. Moreover, the company is investing in a new Thai facility to expand its production capacity. Kentaro Yanashima, Research & Business Development for Kyowa Hakko Bio, tells NutritionInsight all about the promising potential of HMO’s for both infant and adult nutrition and the company’s expansion plans.




Technical Papers
FormattedPicture

Activate your immune system with IMMUSE®

17 Oct 2022 --- IMMUSE® Lactococcus lactis strain Plasma is a unique, patent-protected, heat-killed lactic acid bacteria strain, more commonly referred to as a postbiotic, with a novel mechanism of action that stimulates immune function at the cellular level.This Technical Paper is from Kyowa Hakko.




Podcasts
FormattedPicture

NewsBite Podcast (Jul 19-23): “Pandemic stress causes ‘alarming’ use of supplements, reveals survey”

26 Jul 2021 --- This week’s NewsBite podcast details how COVID-19 has had a major impact on consumer habits around supplementation, with NPD tackling everything from weight management to immunity. Additionally, Kappa Bioscience investigated the link between COVID-19 outcomes and levels of vitamins D and K2.




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W